First-lineBetnesol

Betamethasone

Long-acting corticosteroid

Antenatal corticosteroid for fetal lung maturation 24–34⁺⁶ weeks.

IM

First-line for

  • Threatened preterm birth 24–34⁺⁶ weeks
  • Planned preterm CS up to 38⁺⁶ weeks (consider)

Mechanism

Crosses placenta → glucocorticoid receptor → ↑ surfactant production, alveolar maturation, ↓ IVH, NEC.

“12-12-24-7”

  • 12 mg IM × 2 doses 24 h apart
  • Maximal effect 24 h–7 days after first dose
  • Single rescue if <34 wks & >7 days since first course

Dosing

Course
12 mg IM, 2 doses 24 h apart

Contraindications

  • AbsoluteActive systemic infection (e.g. TB, chorioamnionitis — relative)
  • CautionMaternal diabetes — expect 24–72 h hyperglycaemia

Side effects

  • Maternal hyperglycaemia
  • Transient ↓ fetal movements & HRV
  • Maternal pulmonary oedema (with tocolytics)

Fetal & maternal notes

  • Reduces neonatal mortality by ~30%.
  • Repeat courses not routinely recommended — single rescue only.

Key interactions

  • Insulin

    Caution

    Hyperglycaemia — increase insulin 24–72 h

  • Tocolytics + fluids

    Avoid

    Pulmonary oedema risk

Clinical pearls

  • 💡 Counsel about ↓ fetal movements for 48 h.
  • 💡 Do not delay delivery solely to complete course in severe pre-eclampsia.

Content last reviewed: REPLACE_ME (e.g. 2026-07)

Spotted something out of date? See our disclaimer or use Report an Error above.

For educational use only

Not medical advice. Verify dosing against the BNF and your local trust guidelines before prescribing.